嗜水气单胞菌生物被膜对其耐药性的影响

建立了嗜水气单胞菌(Aeromonas hydrophila, Ah)的生物被膜(Bacterial biofilm, BF) 体外形成模型, 并对11种抗菌药物对BF细菌和浮游（Freecell, FC）细菌的清除作用进行了研究。将Ah J1株在放有硅胶膜的TSB中培养7d,用银染法鉴定,发现可形成良好的BF。FC细菌对青霉素具有耐药性, 最低杀菌浓度(MBC)为256μg/mL;对蒽诺沙星和氟哌酸最敏感,MBC分别为003μg/mL和0.25μg/mL。氟苯尼考对BF细菌的清除能力最强,作用于BF细菌和FC细菌的MBC之比为2∶1;卡那霉素、青霉素、新霉素的MBC比值在32∶1以上。扫描电镜观察蒽诺沙星作用于FC及BF细菌前后的形态变化,并测定其杀菌曲线。发现4×MBC时可完全清除FC细菌,但不能完全清除BF细菌;在32×MBC时,4h内可完全清除FC细菌,而24h内完全清除BF细菌。结果表明形成BF的Ah对抗菌药物可形成强耐受性,其潜在影响应引起足够重视。     

细菌生物被膜检测方法的研究进展

细菌生物被膜(bacterial biofilm,BF)是细菌黏附于接触物表面,由细菌自身分泌的胞外基质包裹形成的多细胞微生物群体,是微生物界细菌普遍的生存状态。基于生物被膜的物理屏障作用和膜内特殊微环境,其具有多重耐药性以及较强的黏附性、抗吞噬性等特性,导致所致疾病迁延不愈,已成为医疗卫生领域的重大挑战。早期、快速、准确检测生物被膜形成对及时有效防治其感染性疾病至关重要。现从表型和基因型检测两个方面对细菌生物被膜检测方法作一综述。     

信号分子调控细菌生物被膜形成的分子机制

细菌生物被膜(Bacterial biofilm,BF)是黏附于机体黏膜或生物材料表面、由细菌及其分泌的多聚糖、蛋白质和核酸等组成的被膜状生物群体,是造成持续性感染的重要原因之一。细菌在生长繁殖时会产生一些次级代谢产物,部分会作为生物信号分子在细胞内或细胞间传递信息,使细菌在多细胞水平协调统一相互配合,以完成一些重要的生理学功能,如生物发光、BF的形成、运动与固定态生活方式的转换等。信号分子在BF形成过程中起着重要的调控作用。文中从密度感应系统(Quorum-sensing systems,QS)、环二鸟苷酸(Cyclic diguanylate,c-di-GMP)、双组分系统(Two-component systems,TCS)和sRNA等方面介绍影响BF形成的相关信号分子,重点对BF形成过程中的信号分子调控机制进行概述,这对于深入揭示信号分子调控BF形成的机制十分必要。     

和厚朴酚抑制耐甲氧西林金黄色葡萄球菌生物被膜形成

【目的】研究和厚朴酚(HNK)抑制MRSA生物被膜(BF)形成的作用机制。【方法】使用TTC法测定了HNK对供试菌株BF的形成和成熟BF的抑制作用;刚果红平板法定性检测了HNK对PIA合成的影响;分光光度法测定了HNK对供试菌株eDNA释放量的影响;RT-PCR技术检测了HNK对供试菌株icaA、cidA以及agrA基因表达量的影响。【结果】HNK对MRSA 41573 BF的形成和成熟BF均有较强的抑制作用,其中,HNK抑制MRSA 41573 BF形成的MIC和MBC分别为10μg/mL和20μg/mL;抑制成熟BF的MIC和MBC分别为50μg/mL和100μg/mL。当用亚抑菌浓度的HNK与万古霉素联合作用后,可显著提高成熟BF对万古霉素的敏感性。HNK能显著抑制PIA的合成,且呈浓度剂量依赖。HNK能抑制供试菌株eDNA的释放量,其中1/8 MIC的HNK作用供试菌株16 h后,与对照组相比,e DNA的释放量降低了28.3%。HNK可抑制供试菌株BF形成的相关基因,其中1/2 MIC的HNK作用供试菌株16 h后,与对照相比,icaA的表达量降低了59.1%,cidA的表达量降低了56%,agrA的表达量降低了72.3%。【结论】HNK能显著抑制MRSA 41573 BF的形成,其作用机制主要是通过抑制icaA和cidA基因表达量,影响PIA和eDNA的合成,进而抑制BF的形成。此外HNK也可通过调控细菌的QS系统影响BF的形成。     

和厚朴酚对大肠埃希氏菌生物被膜形成的抑制机制

【目的】研究不同浓度的和厚朴酚(honokiol)抑制大肠埃希菌(Escherichia coli)的供试菌株10389生物被膜(biofilm,BF)形成的作用机制。【方法】用氯化三苯基四氮唑比色法(TTC)和四唑盐减低法(XTT)测定honokiol抑制E.coli10389生物被膜形成的药物最低抑菌浓度(MIC)和最低杀菌浓度(MBC)及其抑制作用与时间的关系;通过qRT-PCR法检测不同浓度的honokiol对E. coli 10389生物被膜形成基因和群体感应系统相关基因表达量的影响;通过生物发光法和qRT-PCR法检测亚-MIC honokiol对E. coli 10389呋喃糖基硼酸二酯(AI-2)及其调控的与生物被膜形成相关的下游基因表达量的影响。【结果】Honokiol能抑制E.coli10389生物被膜的形成,但不同浓度的honokiol抑制E. coli 10389 BF形成的作用机制不同。其中,与对照组相比,MIC的honokiol能使E. coli 10389 BF形成相关基因编码毒素(hha)和细菌酸性调节因子(ari R) mRNA的表达量显著提高,抗毒素...     

铜绿假单胞菌生物被膜与宿主免疫的关系

铜绿假单胞菌(Pseudomonas aeruginosa,P.aeruginosa)是一种常见的革兰阴性条件致病菌,能引起严重的院内感染,可从支气管扩张、肺囊性纤维化(CF)等患者体内分离。机体免疫系统可以通过识别不同的病原体相关分子模式(PAMPs)来抵御P.aeruginosa的感染,但P.aeruginosa生物被膜(BF)的形成可以导致这些成分被遮蔽从而引起免疫逃逸,导致疾病的迁延难愈。BF是一种与游离细菌相对立的生活方式,能帮助细菌有效适应外部环境,其可以通过藻酸盐的屏障作用,抵抗吞噬细胞的吞噬,干扰多核白细胞(PMNs)的激活,从而逃避宿主免疫。研究P.aeruginosa-BF的免疫逃逸机制,发现有效清除P.aeruginosa-BF的方法,从而为临床治疗P.aeruginosa引起的感染性疾病提供科学依据。现以P.aeruginosa为例对近年来国内外BF的免疫逃逸机制的研究进展进行综述。     

群体感应对铜绿假单胞菌生物被膜形成的调控

生物被膜是一种与浮游细胞相对应的生长方式,由细菌和自身分泌的包外基质组成。铜绿假单胞菌是研究这一生长方式的模式生物。在过去十年,对铜绿假单胞菌生物被膜的研究已取得显著进展。群体感应(QS)的细胞沟通机制在铜绿假单胞菌生物被膜形成中发挥着重要作用。介绍生物被膜的特点,并重点讨论了QS和生物被膜之间的关系。     

白花丹素对E.coli藻酸盐合成的抑制作用

细菌分泌的胞外多糖在生物被膜的形成和发展过程中发挥着重要作用。通过测定白花丹素对大肠埃希菌10389菌株(E.coli 10389)藻酸盐合成的影响及其对rse A和rpo E基因表达量的影响,探讨白花丹素对大肠埃希菌生物被膜(biofilm,BF)形成的抑制作用及机制。研究结果显示,白花丹素能抑制E.coli 10389生物被膜的形成,其抑杀E.coli 10389的最低抑菌浓度(minimum inhibitory concentration,MIC)和最低杀菌浓度(minimal bactericidal concentration,MBC)分别为16和64μg/mL。白花丹素对成熟BF内的细菌也有抑制和杀灭作用,其抑杀E.coli 10389成熟BF内细菌的MIC和MBC分别为64和128μg/mL。白花丹素能够抑制E.coli 10389藻酸盐的合成,其中1/2MIC的白花丹素作用E.coli 10389 24 h后,与对照组比,藻酸盐的合成量降低了34.83%(P0.01)。白花丹素可显著影响E.coli 10389 rse A和rpo E基因的相对表达量,其中1/2MIC的白花丹素作用E.coli 10389 24 h后,与对照组相比,rse A的表达量上调了17.43%,rpo E的表达量降低了12.8%(P0.05)。结果表明,白花丹素能够抑制E.coli 10389 BF的形成,其作用机制可通过影响rse A和rpo E的基因表达量,进而抑制藻酸盐的合成来抑制大肠埃希菌生物被膜的形成。     

白念珠菌生物被膜的基因表达及相关基因研究进展

白念珠菌是一种条件性致病菌,可在人体植入性器械表面形成生物被膜.与浮游和以个体形式存在的白念珠菌相比,生物被膜在结构及功能上有很大差异,这种差异本质上是由基因表达决定的.近年来,研究者们试图通过芯片和基因敲除等技术手段,探索与白念珠菌生物被膜形成及耐药相关的基因,揭示其分子机制,寻找药物作用的新靶点.     

细菌群体感应及其在食品变质中的作用

食品相关细菌引起的生物被膜形成和食品变质是食品工业中的重大问题。研究表明细菌群体感应(Quorum sensing,QS)与被膜形成、食品腐败变质密切相关。重点对细菌产生的各种QS信号分子及其在被膜形成的作用和被膜在食品工业中的重要性做了介绍。QS信号分子与食品变质密切相关,故对QS抑制剂作为新型食品防腐剂以延长储存期限及加强食品安全的前景进行了概述。     

The carbon monoxide releasing molecule CORM-2 attenuates Pseudomonas aeruginosa biofilm formation

Chronic infections resulting from biofilm formation are difficult to eradicate with current antimicrobial agents and consequently new therapies are needed. This work demonstrates that the carbon monoxide-releasing molecule CORM-2, previously shown to kill planktonic bacteria, also attenuates surface-associated growth of the gram-negative pathogen Pseudomonas aeruginosa by both preventing biofilm maturation and killing bacteria within the established biofilm. CORM-2 treatment has an additive effect when combined with tobramycin, a drug commonly used to treat P. aeruginosa lung infections. CORM-2 inhibited biofilm formation and planktonic growth of the majority of clinical P. aeruginosa isolates tested, for both mucoid and non-mucoid strains. While CORM-2 treatment increased the production of reactive oxygen species by P. aeruginosa biofilms, this increase did not correlate with bacterial death. These data demonstrate that CO-RMs possess potential novel therapeutic properties against a subset of P. aeruginosa biofilm related infections.     

Biofilm vs. planktonic bacterial mode of growth: Which do human macrophages prefer?

Although the natural mode of bacterial growth in nature is as biofilm, almost all antimicrobial and immunological tests are routinely developed using planktonic inoculums. Bacterial biofilms protect the microbial community from external damage and promote the persistence of chronic infections. In this study, interactions between human macrophages and bacterial inoculums of planktonic and biofilm modes of growth have been explored using Escherichia coli (E. coli) K12. Human macrophages phagocytize planktonic E. coli more efficiently than bacteria grown in a biofilm. Moreover, they prefer to phagocytize planktonic bacteria. In this context, CD64 expression is involved. Our data indicate that bacteria with “a biofilm background” avoid phagocytosis by naïve macrophages, which could create a favorable environment for chronic infection. Our findings were corroborated in a clinical O25b-ST131 ESBL-producer E. coli isolate, which caused urinary tract infections.     

Reverting Antibiotic Tolerance of Pseudomonas aeruginosa PAO1 Persister Cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one

Background

Bacteria are well known to form dormant persister cells that are tolerant to most antibiotics. Such intrinsic tolerance also facilitates the development of multidrug resistance through acquired mechanisms. Thus persister cells are a promising target for developing more effective methods to control chronic infections and help prevent the development of multidrug-resistant bacteria. However, control of persister cells is still an unmet challenge.

Methodology/Principal Findings

We show in this report that (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one (BF8) can restore the antibiotic susceptibility of Pseudomonas aeruginosa PAO1 persister cells at growth non-inhibitory concentrations. Persister control by BF8 was found to be effective against both planktonic and biofilm cells of P. aeruginosa PAO1. Interestingly, although BF8 is an inhibitor of quorum sensing (QS) in Gram-negative bacteria, the data in this study suggest that the activities of BF8 to revert antibiotic tolerance of P. aeruginosa PAO1 persister cells is not through QS inhibition and may involve other targets.

Conclusion

BF8 can sensitize P. aeruginosa persister cells to antibiotics.     

Controlling persister cells of Pseudomonas aeruginosa PDO300 by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one

Pseudomonas aeruginosa is a major pathogen causing chronic pulmonary infections; for example, 80% of cystic fibrosis patients get infected by this bacterium as the disease progresses. Such chronic infections are challenging because P. aeruginosa exhibits high-level tolerance to antibiotics by forming biofilms (multicellular structures attached to surfaces), by entering dormancy and forming antibiotic tolerant persister cells, and by conversion to the mucoid phenotype. Recently, we reported that a synthetic quorum sensing inhibitor, (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one (BF8), can sensitize both planktonic and biofilm-associated persister cells of P. aeruginosa PAO1 to antibiotics at the concentrations non-inhibitory to its growth. In this study, we further characterized the effects of this compound on the mucoid strain P. aeruginosa PDO300. BF8 was found to reduce persistence during the growth of PDO300 and effectively kill the persister cells isolated from PDO300 cultures. In addition to planktonic cells, BF8 was also found to inhibit biofilm formation of PDO300 and reduce associated persistence. These findings broaden the activities of this class of compounds and indicate that BF8 also has other targets in P. aeruginosa in addition to quorum sensing.     

柱[5]芳烃衍生物对细菌抗菌活性及生物被膜抑制的研究进展北大核心

病原体的耐药性很强,其生物被膜(biofilm,BF)的形成是导致耐药性的主要原因之一。生物被膜一旦形成,根除难度很大,会导致患者持久性感染,引发多种慢性疾病,并给全球医疗体系带来沉重负担。柱芳烃(pillararenes)是一类具有独特柱状结构的新型大环化合物,由于其在构建功能化和生物活性材料开发中的潜在应用引起人们广泛的关注。此外,它们在预防和控制抗生素耐药性(antimicrobial resistance,AMR)方面具有广阔的应用前景。本文综述了柱[5]芳烃衍生物对细菌病原菌的抗菌活性,并进一步揭示其在抗菌活性中的抑菌机制,尤其是对生物被膜的抑制作用。在此基础上,探索新的抑菌杀菌策略,用非传统药物以解决抗生素耐药性问题,以期为开发新的抗菌剂防控生物被膜或治疗细菌感染提供理论依据。     

乳杆菌对生物膜的作用及其机制研究进展

慢性炎症和感染性疾病与致病菌生物膜(biofilm,BF)的形成密切相关,目前治疗BF相关疾病还局限于应用抗生素,但抗生素滥用会导致多重耐药,治疗不彻底会引起慢性感染,预防和治疗BF相关疾病的新方法亟待提出。随着益生菌生物制剂应用价值的不断体现与验证,益生菌生物制剂不断发展为消除某些致病菌BF感染的新方案。其中发展的最好的莫过于乳杆菌活菌制剂,大量的科研文献及临床实践已证明其具有强大的益生潜力,特别是在抑制致病菌生物膜方面,这为临床治疗BF相关感染开拓了新视野。本文主要综述当前国内外乳杆菌对生物膜作用及其机制的研究进展,旨在通过综述相关研究进展为临床治疗生物膜相关感染提供全新思路。     

Erosion from Staphylococcus aureus biofilms grown under physiologically relevant fluid shear forces yields bacterial cells with reduced avidity to collagen

An estimated 65% of infective diseases are associated with the presence of bacterial biofilms. Biofilm-issued planktonic cells promote blood-borne, secondary sites of infection by the inoculation of the infected sites with bacteria from the intravascular space. To investigate the potential role of early detachment events in initiating secondary infections, we studied the phenotypic attributes of Staphylococcus aureus planktonic cells eroding from biofilms with respect to expression of the collagen adhesin, CNA. The collagen-binding abilities of S. aureus have been correlated to the development of osteomyelitis and septic arthritis. In this study, we focused on the impact of CNA expression on S. aureus adhesion to immobilized collagen in vitro under physiologically relevant shear forces. In contrast to the growth phase-dependent adhesion properties characteristic of S. aureus cells grown in suspension, eroding planktonic cells expressed invariant and lower effective adhesion rates regardless of the age of the biofilm from which they originated. These results correlated directly with the surface expression level of CNA. However, subsequent analysis revealed no qualitative differences between biofilms initiated with suspension cells and secondary biofilms initiated with biofilm-shed planktonic cells. Taken together, our findings suggest that, despite their low levels of CNA expression, S. aureus planktonic cells shed from biofilms retain the capacity for metastatic spread and the initiation of secondary infection. These findings demonstrate the need for a better understanding of the phenotypic properties of eroding planktonic cells, which could lead to new therapeutic strategies to target secondary infections.     

细菌生物薄膜相关感染的靶向治疗

细菌依其生存的环境不同能够在生物薄膜和浮游细菌两种生存形式之间转换。细菌生物薄膜的形成导致对抗生素治疗的低敏感性,是慢性感染过程中的重要因素。细菌生物薄膜形成过程涉及多种因素,相当部分已被证实为抑制生物薄膜形成的潜在靶点。本文主要就近几年抑制生物薄膜形成的靶点筛选作一介绍。